×
Quoin Pharmaceuticals Price/Book Ratio 2016-2025 | QNRX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Quoin Pharmaceuticals price/book ratio from 2016 to 2025. Price/book ratio can be defined as
View More
Quoin Pharmaceuticals Price/Book Ratio 2016-2025 | QNRX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Quoin Pharmaceuticals price/book ratio from 2016 to 2025. Price/book ratio can be defined as
Related Stocks
Company Name
Market
Cap
Chugai Pharmaceutical (CHGCY)
$77.5B
Zoetis (ZTS)
$65.6B
Daiichi Sankyo, - (DSNKY)
$46.1B
Takeda Pharmaceutical (TAK)
$45.9B
BeOne Medicines - (ONC)
$32B
Sandoz Group AG (SDZNY)
$25.2B
Summit Therapeutics (SMMT)
$19.6B
Merck (MKKGY)
$16.6B
Shionogi (SGIOY)
$14.4B
United Therapeutics (UTHR)
$13.2B
Neurocrine Biosciences (NBIX)
$13B
Orion OYJ (ORINY)
$11B
IPSEN (IPSEY)
$10.5B
Corcept Therapeutics (CORT)
$7.4B
Madrigal Pharmaceuticals (MDGL)
$7.3B
Stevanato Group S.p.A (STVN)
$7.3B
Grifols, S.A (GRFS)
$6.9B
Ionis Pharmaceuticals (IONS)
$6.6B
Hikma Pharmaceuticals Plc (HKMPF)
$6.2B
Ono Pharmaceutical (OPHLF)
$5.2B
Soleno Therapeutics (SLNO)
$4.4B
Procaps Group, S.A (PROCF)
$3.2B
Hypermarcas (HYPMY)
$3B
Crinetics Pharmaceuticals (CRNX)
$2.9B
Catalyst Pharmaceuticals (CPRX)
$2.6B
NewAmsterdam Pharma (NAMS)
$2.5B
AMNEAL PHARMACEUTICALS, INC (AMRX)
$2.5B
Centessa Pharmaceuticals (CNTA)
$2.1B
Ocular Therapeutix (OCUL)
$1.8B
BioCryst Pharmaceuticals (BCRX)
$1.8B